All News Top News Feb 19, 2019 Teva Finalizes Settlement with Federal Trade Commission to Resolve All Outstanding Litigation between the Parties Learn More Share Top News Feb 13, 2019 Teva Reports Fourth Quarter and Full Year 2018 Financial Results Learn More Share Top News Feb 6, 2019 Teva Announces U.S. Launch of a Generic Version of Sabril® (Vigabatrin) Learn More Share Top News Feb 5, 2019 Teva Announces Launch of ALYQ™ (Tadalafil Tablets USP), a Generic Version of ADCIRCA® in the United States Learn More Share Top News Feb 1, 2019 Teva Receives Positive Committee for Medicinal Products for Human Use (CHMP) Opinion for AJOVY® (fremanezumab) for the Prophylaxis of Migraine in Adults Learn More Share
Top News Feb 19, 2019 Teva Finalizes Settlement with Federal Trade Commission to Resolve All Outstanding Litigation between the Parties Learn More
Top News Feb 6, 2019 Teva Announces U.S. Launch of a Generic Version of Sabril® (Vigabatrin) Learn More
Top News Feb 5, 2019 Teva Announces Launch of ALYQ™ (Tadalafil Tablets USP), a Generic Version of ADCIRCA® in the United States Learn More
Top News Feb 1, 2019 Teva Receives Positive Committee for Medicinal Products for Human Use (CHMP) Opinion for AJOVY® (fremanezumab) for the Prophylaxis of Migraine in Adults Learn More